Skip to Main Content

Paper Details

First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.
Clin Cancer Res
26
2022
Author NameAffiliation
Lillian L SiuPrincess Margaret Cancer Center, University of Toronto
Corinne Maurice-Dror
  • 1 - 2

Datasets

Release 1.2